Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
AstraZeneca
Moodys
McKesson
Harvard Business School

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016092

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 016092 describes EDECRIN, which is a drug marketed by Bausch and is included in two NDAs. It is available from two suppliers. Additional details are available on the EDECRIN profile page.

The generic ingredient in EDECRIN is ethacrynic acid. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the ethacrynic acid profile page.
Summary for 016092
Tradename:EDECRIN
Applicant:Bausch
Ingredient:ethacrynic acid
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 016092
Medical Subject Heading (MeSH) Categories for 016092
Suppliers and Packaging for NDA: 016092
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EDECRIN ethacrynic acid TABLET;ORAL 016092 NDA Aton Pharma, Inc. 25010-215 25010-215-15 100 TABLET in 1 BOTTLE (25010-215-15)
EDECRIN ethacrynic acid TABLET;ORAL 016092 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-011 68682-011-10 100 TABLET in 1 BOTTLE (68682-011-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Dow
Boehringer Ingelheim
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.